Browsing category:

Drug Research & Development API


Linezolid is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. A member of the oxazolidinone class of drugs, Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). MRSA is especially troublesome[…]

Read More

Liraglutide Diabetes Control Liraglutide is a newly developed drug that is used to control the levels of blood glucose in patients suffering from type 2 Diabetes. In January 2010, the US Food and Drug Administration approved this drug for the treatment of patients with diabetes. Liraglutide was approved by the European Medicines Agency (EMEA) in[…]

Read More

Eltrombopag is an effective drug that can help patients suffering from thrombocytopenia. This disease occurs when the percentage of platelets in the patient’s blood decreases to abnormally low levels.  The molecule of Eltrombopag acts as an agonist for TpoR receptor and it stimulates the thrombopoietin hormone which helps to increase the presence of platelets in[…]

Read More

Dextromethorphan Hydrobromide is a well known cough suppressant drug. During a research study jointly funded by the CIA and the US Navy, Dextromethorphan Hbr was established as a non-addictive substitute for Codeine, a common cough depressant. Codeine is an analgesic, which is addictive in nature. In 1958, the U.S. Food and Drug Administration approved this[…]

Read More

Pizotifen Uses: Pizotifen, also known as pizotylin, is a preventive medicine based on benzocycloheptane, that is used to prevent or to reduce the occurrence of migraine attacks,  vascular headache and cluster tension headaches. Pizotifen can also be used as anti-depressant to cure social phobia and anxiety. Pizotifen is usually considered as an effective treatment for migraine prevention[…]

Read More

Darunavir Ethanolate CAS# 635728-49-3 is a second-generation protease inhibitor (PIs), designed specifically to overcome problems with the older agents in this class, such as indinavir. Darunavir was designed to form robust interactions with the protease enzyme from many strains of HIV, including strains from treatment-experienced patients with multiple resistance mutations to PIs. Darunavir is always[…]

Read More